Fig. 3 | Scientific Reports

Fig. 3

From: Computational and pharmacophore-based study of Camellia sinensis phytochemicals targeting BRAF in melanoma

Fig. 3

Figure indicate visualize binding modes of the selected three compounds including (A) theaflagallin (CID: 73818214), (B) epigallocatechin 3-O-cinnamate (CID: 21629801), (C) epicatechin gallate (CID: 107905), control drug (D) plixorafenib (CID: 90116675) and co-crystalized ligand (E) 2-{4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethanol (CID: 11717001) against BRAF (PDB ID: 4MNF) protein. All 3D figures were generated by using Biovia Discovery Studio Visualizer v21 (https://discover.3ds.com/discovery-studio-visualizer-download).

Back to article page